Sign in
Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase
Conference proceeding   Open access  Peer reviewed

Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase

Christopher M REILLY, Libby W FARRELLY, Dana VITI, Shakisha T REDMOND, Florence HUTCHISON, Phil RUIZ, Pam MANNING, Jane CONNOR and Gary S GILKESON
Kidney international, Vol.61(3), pp.839-846
Forefronts in Nephrology: Nitric Oxide and Inflammation
2002
PMID: 11849435

Abstract

Glomerulonephritis Nephrology. Urinary tract diseases Biological and medical sciences Medical sciences Nephropathies. Renovascular diseases. Renal failure
url
https://doi.org/10.1046/j.1523-1755.2002.00230.xView
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Industry collaboration
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.127 Molecular & Cell Biology - Pharmacology
1.127.87 Nitric Oxide
Web Of Science research areas
Urology & Nephrology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details